Board-certified gastroenterologist, Eric Montminy, MD, specializes in digestive disorders with expertise in interventional endoscopy, a field of gastroenterology that specializes in minimally invasive procedures using endoscopy to diagnose and treat conditions in the digestive tract. Dr. Montminy has extensive experience performing therapeutic and diagnostic endoscopic ultrasound, endoscopic retrograde cholangiopancreatography (ERCP), endoscopic resections, endoscopic ablation, and more to provide advanced care for patients with pancreatic diseases, biliary diseases, gastrointestinal cancers, and pre-malignant cancers.
Because Dr. Montminy understands how complicated and personal digestive conditions can be, he is committed to offering high-quality, compassionate care to his patients and provides treatment plans tailored to their specific needs. His goal is to help his patients improve their gastrointestinal health and overall well-being. Ultimately, he strives to make progress in your care through a collaborative approach with your doctors.
In addition to clinical work, Dr. Montminy uses research to enhance treatments for gastroenterology patients. He has investigated various interventional endoscopy technique outcomes as well as incidences and staging of gastrointestinal cancers in order to identify and understand GI malignancy earlier. His research has been published in several highly respected, peer-reviewed journals, including Annals of Internal Medicine, Gastroenterology, JAMA Network Open, Clinical Gastroenterology and Hepatology and more. His research has been incorporated into recommendation statements by the United States Preventive Services Task Force and the United States Multi-Society Task Force on colorectal cancer screening.
Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis.
Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers (Basel). 2025 Apr 29; 17(9).
PMID: 40361427
Large Single Center Comparison of Novel and Reusable Duodenoscopes Shows Similar Contamination Rates That Do Not Correlate With Clinical Infection.
Large Single Center Comparison of Novel and Reusable Duodenoscopes Shows Similar Contamination Rates That Do Not Correlate With Clinical Infection. Am J Gastroenterol. 2025 Feb 05.
PMID: 39907237
A rendezvous approach for ampullary access in a strictured duodenojejunostomy.
A rendezvous approach for ampullary access in a strictured duodenojejunostomy. VideoGIE. 2025 May; 10(5):250-252.
PMID: 40255627
Stage-Stratified Incidence Rates of Colorectal Adenocarcinoma Among Patients Aged 46 to 49 in the United States.
Stage-Stratified Incidence Rates of Colorectal Adenocarcinoma Among Patients Aged 46 to 49 in the United States. JAMA Netw Open. 2024 03 04; 7(3):e241848.
PMID: 38488798
Endoscopic iatrogenic esophageal perforation and management: a retrospective outcome analysis in the modern era.
Endoscopic iatrogenic esophageal perforation and management: a retrospective outcome analysis in the modern era. BMC Gastroenterol. 2023 Oct 31; 23(1):371.
PMID: 37907880
Impact of Carcinoid and Appendiceal Site Inclusion on Early Onset Colon Cancer Incidence Rate Analysis in the United States.
Impact of Carcinoid and Appendiceal Site Inclusion on Early Onset Colon Cancer Incidence Rate Analysis in the United States. Clin Gastroenterol Hepatol. 2023 10; 21(11):2972-2974.e1.
PMID: 36273798
One-year Increment Staging Incidence of Esophageal Adenocarcinoma With Enhanced Ethnicity Surveillance, Epidemiology, and End Results Program 18 Sampling, 2000-2017.
One-year Increment Staging Incidence of Esophageal Adenocarcinoma With Enhanced Ethnicity Surveillance, Epidemiology, and End Results Program 18 Sampling, 2000-2017. Gastro Hep Adv. 2023; 2(1):5-7.
PMID: 39130151
Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States.
Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.
PMID: 35082122
Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50.
Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2023 03; 21(3):827-829.e3.
PMID: 34800736
Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017.
Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017. JAMA Netw Open. 2021 11 01; 4(11):e2130433.
PMID: 34751760